FP
ELV icon

FDO Partners’s Elevance Health ELV Stock Holding History

FDO Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,442
Closed -$274K – 194
2017
Q3 		$274K Buy
+1,442
New +$274K 0.11% 190
2017
Q2 		– Sell
-11,996
Closed -$1.98M – 255
2017
Q1 		$1.98M Buy
11,996
+2,968
+33% +$472K 0.49% 84
2016
Q4 		$1.3M Sell
9,028
-14,168
-61% -$1.9M 0.52% 85
2016
Q3 		$2.91M Buy
23,196
+13,451
+138% +$1.74M 1.25% 11
2016
Q2 		$1.28M Buy
9,745
+7,603
+355% +$1.04M 0.69% 52
2016
Q1 		$298K Sell
2,142
-2,400
-53% -$321K 0.19% 181
2015
Q4 		$633K Buy
+4,542
New +$626K 0.36% 120

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

FDO Partners's ELV Position: Q4 2017 in Review

FDO Partners sold out of Elevance Health (ELV) in Q4 2017, closing a stake of 1,442 shares — an estimated $274K sold.

FDO Partners first reported a position in ELV in Q4 2015 and held it in 7 quarters. The position peaked at $2.91M in Q3 2016. 909 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

  • FDO Partners reported no remaining Elevance Health position as of Q4 2017 after selling out during the quarter.
  • FDO Partners sold 1,442 Elevance Health shares in Q4 2017, an estimated $274K.
  • FDO Partners first reported a position in Elevance Health in Q4 2015 and held it in 7 quarters.
  • FDO Partners's Elevance Health position peaked at $2.91M in Q3 2016.
  • 909 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on FDO Partners's 13F filing for Q4 2017, filed 13 Feb 2018.